The use of the Chuang′s prognostic scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy
Open Access
- 1 January 2016
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Palliative Care
- Vol. 22 (3), 312-316
- https://doi.org/10.4103/0973-1075.185043
Abstract
Background: With the increasing number of agents active against cancer, advanced cancer patients including metastatic colorectal cancer (mCRC) patients may continue receiving palliative systemic anticancer therapy (PSAT) near the end-of-life. Validated palliative prognostic models, such as the Chuang's prognostic scale (CPS), may be helpful in identifying mCRC patients with limited survival who are unlikely to benefit from PSAT. Aim: To test the ability of the CPS to predict the survival of mCRC under treatment with PSAT. Methods: CPS was prospectively assessed in 36 mCRC patients who were receiving PSAT. The scale is based on eight items: ascites, edema, cognitive impairment, liver and lung metastases, performance status, tiredness, and weight loss. The total CPS score ranges from 0 to 8.5 with the higher score indicating worse prognosis. Results: Patients were divided into two groups using a CPS cutoff score of 5, Group 1 with a CPS score ≤5 and Group 2 with a CPS score >5. Using this cutoff value, 3-month mortality was predicted with a positive predictive value of 71%, a negative predictive value of 77%, a sensitivity of 67%, a specificity of 81% and an overall accuracy of 75%. Group 1 patients had a longer median survival of 149 days (95% confidence interval [CI]: 82-216) in comparison to Group 2 patients who had a median survival of 61 days (95% CI: 35-87). The difference in survival was statistically significant (P = 0.01). Conclusion: CPS may be useful in identifying mCRC patients with limited survival who are unlikely to benefit from PSAT.Keywords
This publication has 16 references indexed in Scilit:
- Trends in receiving chemotherapy for advanced cancer patients at the end of lifeBMC Palliative Care, 2015
- Recent Therapeutic Advances in the Treatment of Colorectal CancerAnnual Review of Medicine, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort studyBMJ, 2014
- Targeted Agent Use in Cancer Patients at the End of LifeJournal of Pain and Symptom Management, 2012
- Targeted Therapy at the End of Life in Advanced Cancer PatientsJournal of Palliative Medicine, 2012
- Quality Indicators for Care of Cancer Patients in Their Last Days of Life: Literature Update and Experts' EvaluationJournal of Palliative Medicine, 2012
- Trends in the Aggressiveness of End-of-Life Cancer Care in the Universal Health Care System of Ontario, CanadaJournal of Clinical Oncology, 2011
- Use of chemotherapy at end of life in oncology patientsAnnals of Oncology, 2009
- Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scaleJournal of Pain and Symptom Management, 2004